Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

28.40
+0.05000.18%
Post-market: 28.400.00000.00%16:25 EDT
Volume:841.01K
Turnover:23.81M
Market Cap:4.51B
PE:-9.35
High:28.76
Open:28.31
Low:28.04
Close:28.35
Loading ...
Nov 04, 2020

Major Issues Report

8-K - Current report
Oct 13, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 13, 2020

Major Issues Report

8-K - Current report
Oct 02, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 24, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 31, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 31, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jun 10, 2020

Major Issues Report

8-K - Current report
May 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 02, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals